Determination of dextromethorphan and dextrorphan in human urine by high performance liquid chromatography for pharmacogenetic investigations

被引:8
作者
Flores-Pérez, J
Flores-Pérez, C
Juárez-Olguín, H
Lares-Asseff, I
Sosa-Macías, M
机构
[1] Inst Nacl Pediat, Farmacol Lab, Mexico City 04530, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Dept Farmacol, Mexico City 04510, DF, Mexico
[3] Inst Politec Nacl Mexico, Ctr Interdisciplinario Invest Desarollo Integral, Durango, Mexico
关键词
column liquid chromatography; pharmacogenetic studies; dextromethorphan and dextrorphan; urine samples; Mexican ethnic groups;
D O I
10.1365/s10337-004-0224-x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the present study was to develop a sensitive method to measure dextromethorphan and dextrorphan in urine by HPLC to support pharmacogenetic studies in ethnic groups. Linearity was assessed in the range: 0.015-10 mug mL(-1) for dextromethorphan and 1-10 mug mL(-1) for dextrorphan. Inter and intra-day coefficients of variation were < 10%. Limits of detection and quantitation were 0.003 mug mL(-1) and 0.015 mug mL(-1) for dextromethorphan and 0.24 mug mL(-1) and 1.0 mug mL(-1) for dextrorphan, respectively. The method is reliable in helping determine the phenotype of Mexican ethnic groups using model drugs such as dextromethorphan.
引用
收藏
页码:481 / 485
页数:5
相关论文
共 20 条
[1]   HYDROXYLATION POLYMORPHISMS OF DEBRISOQUINE AND MEPHENYTOIN IN EUROPEAN POPULATIONS [J].
ALVAN, G ;
BECHTEL, P ;
ISELIUS, L ;
GUNDERTREMY, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) :533-537
[2]   High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations [J].
Bendriss, EK ;
Markoglou, N ;
Wainer, IW .
JOURNAL OF CHROMATOGRAPHY B, 2001, 754 (01) :209-215
[3]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[4]  
CAI WM, 1997, BAO, V32, P861
[5]   Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity [J].
Ducharme, J ;
Abdullah, S ;
Wainer, IW .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 678 (01) :113-128
[6]  
EVANS DAP, 1995, PHARMACOGENETICS, V5, P64
[7]   DEXTROMETHORPHAN AND CAFFEINE AS PROBES FOR SIMULTANEOUS DETERMINATION OF DEBRISOQUIN-OXIDATION AND N-ACETYLATION PHENOTYPES IN CHILDREN [J].
EVANS, WE ;
RELLING, MV ;
PETROS, WP ;
MEYER, WH ;
MIRRO, J ;
CROM, WR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) :568-573
[8]   METOPROLOL AND MEPHENYTOIN OXIDATION POLYMORPHISMS IN FAR EASTERN ORIENTAL SUBJECTS - JAPANESE VERSUS MAINLAND CHINESE [J].
HORAI, Y ;
NAKANO, M ;
ISHIZAKI, T ;
ISHIKAWA, K ;
ZHOU, HH ;
ZHOU, BJ ;
LIAO, CL ;
ZHANG, LM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :198-207
[9]   MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS [J].
INABA, T ;
JURIMA, M ;
NAKANO, M ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :670-676
[10]   CYP2D6-related oxidation polymorphism in a Canadian Inuit population [J].
JurimaRomet, M ;
Foster, BC ;
Casley, WL ;
Rode, A ;
Vloshinsky, P ;
Huang, HS ;
Geertsen, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (03) :165-172